Recently, the first robot-assisted cerebral angiography surgery in China was successfully performed at Beijing Tiantan Hospital, affiliated with Capital Medical University. It is reported that the robot used in this surgery, named "Luban," is a domestically developed robot dedicated to minimally invasive vascular intervention surgery.
Cerebral angiography surgery is an X-ray examination technique that involves injecting contrast agents into arterial blood vessels to dynamically display the morphology, location, distribution, and course of major blood vessels in the brain. It is widely used in the diagnosis of cerebrovascular diseases, especially for qualitative and positional diagnosis of arterial aneurysms and arteriovenous malformations.
Robot-assisted surgery systems are comprehensive entities that integrate multiple modern high-tech methods. They have a wide range of applications in clinical and surgical fields. Surgeons can perform surgery remotely from the operating table, which is completely different from traditional surgical concepts. In the field of minimally invasive surgery, robot-assisted surgery tools are considered revolutionary.
These systems are mainly used in cardiac surgery and prostatectomy. Surgeons can manipulate the robot from a distance, without physically touching the patient. Once the incision site is determined, a mechanical arm equipped with a camera and other surgical tools will perform actions such as cutting, hemostasis, and suturing. The surgeon only needs to sit at the control console, usually in the operating room, to observe and guide the robotic arm's work. It is reported that this technology allows surgeons to perform surgeries on patients at the other end of the earth. Currently, the most common robot-assisted surgery is prostatectomy. In the United States alone, robots successfully completed 20,000 various surgeries, including prostatectomy and cardiac surgery, in 2004. The use of robots in surgery reduces bleeding compared to traditional open surgery. Patients who undergo robot-assisted surgery can be discharged after one day and resume normal activities after one week, while patients who undergo traditional open surgery usually require 2-3 days of hospitalization and 6 weeks to recover.
Furthermore, in the case of prostatectomy, for example, if the surgery is performed incorrectly and the nerves surrounding the prostate are severed, it can lead to impotence. Therefore, precise incisions are crucial. Traditional prostatectomy has a 25% to 60% impotence rate among patients. However, the use of robots in surgery significantly reduces the rate of impotence. Cardiac surgeons who use robots for surgery, such as repairing mitral valves and performing arterial surgery, do not need to open the ribs. The incision for patients is only 3.7 to 5 centimeters, compared to the traditional surgery's incision of 20 to 25 centimeters. This reduces patient pain, bleeding, and trauma. Apart from costs and technical issues, robot-assisted surgery is considered superior to non-robot-assisted surgery to some extent.
On the day of the surgery, the control room of the catheterization laboratory at Tiantan Hospital was crowded with doctors who came to observe the surgery. After establishing vascular access, Dr. Jiang Yuhua, the chief interventionalist, went to the doctor's main operating console outside the operating room and remotely controlled the interventional robot "Luban" using two joysticks. He accurately performed angiography on the patient's left and right carotid arteries, subclavian arteries, and vertebral arteries. The delivery and rotation of the catheter and guidewire during the procedure were smooth and stable. The examination results showed complete embolization of the aneurysm, and the carrier artery was unobstructed.
The "Luban" minimally invasive vascular intervention robot used in this surgery was developed by Professor Li Youxiang's clinical research team at Tiantan Hospital and Professor Xiao Nan's robot technology team at Beijing Institute of Technology. It is a minimally invasive vascular intervention surgical robot system with complete independent intellectual property rights. The project has achieved breakthroughs in key technologies of minimally invasive interventional surgery robots during the implementation process. This achievement also marks the imminent clinical application of domestically produced and independently developed minimally invasive vascular intervention surgical robots, alleviating the shortage of high-quality interventional medical resources and narrowing the technological gap between China and international advanced levels.
Currently, this surgical robot is positioned for use in the field of interventional neuroradiology, and the development and application of interventional neuroradiology surgical robots will effectively improve China's technological level in the field of vascular intervention surgical robots. With the development of 5G technology in the future, vascular intervention robots will be able to perform surgeries across regions, which can save many patients who cannot travel long distances for medical treatment.
Cerebral angiography surgery involves injecting contrast agents into arterial blood vessels and using related instruments to dynamically display the morphology, location, distribution, and course of major blood vessels in the brain through X-ray examination techniques. This surgery is widely used in the diagnosis of cerebrovascular diseases, especially for qualitative and positional diagnosis of arterial aneurysms and arteriovenous malformations. Usually, medical staff are exposed to radiation throughout the procedure, and although they have strict protective measures, there is still a certain risk associated with long-term exposure. The assistance of the robot "Luban" allows medical staff to stay away from radiation hazards.
Alphabet Q1 paid subscribers reached 350M, fueled by YouTube & Google One. YouTube ad revenue slightly missed at $9.88B amid Premium growth. Total Q1 revenue hit $109.9B, beating forecasts.
Anthropic releases Claude connectors for Adobe, Blender, and Ableton, enabling AI workflow automation and app control. It also sponsors the Blender Development Foundation.
Apple introduces an App Store model splitting 12-month plans into monthly installments. On iOS 26.4+, it lowers upfront costs without reducing total price, adding billing tracking.
Google launches Aadhaar digital IDs in Wallet for India, enabling secure QR/NFC verification. A phased partner rollout targets key sectors, while passport-based credentials expand globally.
YouTube tests "Ask YouTube," an AI tool blending text and video for complex queries. Initially for US Premium users, it supports interactive follow-ups, expanding Google's AI search.
Google grants US DoD classified AI access, joining OpenAI and xAI in defense deals amid Anthropic's dispute. Contractual safeguards against surveillance and lethal weapons remain unenforceable.
Mistral AI launches Workflows, a Temporal-powered orchestration platform for secure, Python-driven enterprise AI automation featuring human-in-the-loop approvals.